Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6154)
All Articles published online
|
Publishing Process of This Article
|
Dec 15, 2018 (publication date) through Jun 14, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sunakawa Y, Satake H, Ichikawa W. Considering FOLFOXIRI plus bevacizumab for metastatic colorectal cancer with left-sided tumors. World J Gastrointest Oncol 2018; 10(12): 528-531 [PMID: 30595807 DOI: 10.4251/wjgo.v10.i12.528] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v10/i12/528.htm |
| Number | Citing Articles |
| 1 |
Chiara Nicolazzo, Ludovic Barault, Salvatore Caponnetto, Gianluigi De Renzi, Francesca Belardinilli, Irene Bottillo, Simone Bargiacchi, Marco Macagno, Paola Grammatico, Giuseppe Giannini, Enrico Cortesi, Federica Di Nicolantonio, Paola Gazzaniga. True conversions from RAS mutant to RAS wild-type in circulating tumor DNA from metastatic colorectal cancer patients as assessed by methylation and mutational signature. Cancer Letters 2021; 507: 89 doi: 10.1016/j.canlet.2021.03.014
|
| 2 |
Zoltan P Majdik, S Scott Graham, Jade C Shiva Edward, Sabrina N Rodriguez, Martha S Karnes, Jared T Jensen, Joshua B Barbour, Justin F Rousseau. Sample Size Considerations for Fine-Tuning Large Language Models for Named Entity Recognition Tasks: Methodological Study. JMIR AI 2024; 3: e52095 doi: 10.2196/52095
|